Epogen

Bristol Myers data make case for earlier use of bone marrow disease drug
BioPharma Dive
Thu, 05/25/23 - 08:31 pm
Bristol Myers Squibb
Reblozyl
Epogen
myelodysplastic syndromes
clinical trials
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Pfizer’s Epoetin Alfa Biosimilar Approved by FDA
RAPS.org
Tue, 05/15/18 - 09:14 pm
FDA
Amgen
biosimilars
Epogen
epoetin alfa
Retacrit
Pfizer
What to Expect From Amgen, Inc. in 2018
Motley Fool
Sun, 01/21/18 - 10:40 am
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Will 2018 Be Amgen Inc.'s Best Year Yet?
Motley Fool
Wed, 01/17/18 - 10:08 am
Amgen
Enbrel
Aranesp
Neulasta
Epogen
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Fierce Pharma
Fri, 08/11/17 - 11:22 am
Amgen
Epogen
patents
Pfizer
anemia
biosimilars
FDA Rejects Pfizer's Anemia Drug Biosimilar
Xtalks
Tue, 06/27/17 - 11:50 pm
FDA
Pfizer
biosimilars
Epogen
Amgen
anemia
FDA rejects Pfizer's Epogen biosimilar for the second time
Fierce Pharma
Fri, 06/23/17 - 09:50 am
FDA
Pfizer
biosimilars
Epogen
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
Mon, 05/29/17 - 12:00 pm
FDA
advisory panels
Pfizer
biosimilars
Amgen
Epogen
Procrit
anemia
JNJ
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Fierce Pharma
Wed, 05/24/17 - 10:51 am
Pfizer
Epogen
biosimilars
FDA
advisory panels
Amgen
anemia
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs
Bidness, ETC
Fri, 03/4/16 - 02:09 pm
Amgen
Pfizer
Novartis
Enbrel
Epogen
Amgen's Innovation Counters Biosimilar Pressure
Morningstar
Mon, 10/19/15 - 10:03 am
Amgen
innovation
biosimilars
Epogen
Aranesp
Neupogen
Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar
FDA Law Blog
Thu, 09/24/15 - 09:01 am
Amgen
patents
Hospira
biosimilars
Epogen
Can Sprout's Addyi shrug off serious side effects? These blockbusters did
Fierce Pharma Marketing
Wed, 08/26/15 - 09:24 am
Sprout Pharmaceuticals
Addyi
female sexual dysfunction
side effects
Advair
GSK
Amgen
Epogen
Merck
Fosamax
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Mon, 06/23/14 - 12:53 pm
Amgen
Epogen
anemia
Procrit
JNJ
Generic Threats To Amgen's Biologics
Seeking Alpha
Thu, 06/6/13 - 11:49 am
Amgen
generics
biosimilars
Neupogen
Aranesp
Epogen
[video]3 Amgen Biologics Facing Generic Competition
Motley Fool
Fri, 05/31/13 - 09:28 am
Amgen
generics
Aranesp
Epogen
Neupogen
EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha
Thu, 05/2/13 - 03:50 pm
JNJ
Amgen
Aranesp
Procrit
Epogen

Pages